RCKT

1.9656.87%
ML

Martin Louis Wilson

Gen. Counsel, Secretary, Interim Prin. Financial Officer, Chief Comp. Officer & Chief Corp. Officer

Mr. Martin L. Wilson, J.D., serves as General Counsel and Chief Compliance Officer at Rocket Pharmaceuticals, Inc. since November 2021 and serves as its Corporate Secretary and serves as its Interim Principal Financial Officer since September 08, 2025 and serves as its Chief Corporate Officer since March 2024 and was its Senior Vice President since November 2021 until 2024. Prior to Rocket, Mr. Wilson was General Counsel and Chief Corporate Officer at Ichnos Sciences, where he oversaw Legal, Compliance, Business Development, Human Resources and IT. Mr. Wilson was General Counsel and Chief Corporate Officer at Ichnos Sciences Inc. from January 2020 through November 2021. Prior to his time at Ichnos, Mr. Wilson served as General Counsel at Teligent Inc., a generic pharmaceutical company, from April 2017 through December 2019. Before Ichnos, Mr. Wilson served as Chief Compliance Officer, Corporate Secretary and Head of Human Resources at Teligent, Inc. He had been General Counsel at Teligent, Inc. since April 25, 2017 until December 30, 2019. Prior to joining Teligent, Mr. Wilson served as the Vice President and Assistant General Counsel for Endo Pharmaceuticals' generic arm, Par Pharmaceutical, Inc. a position he held since September 2015. He was with Par prior to Endo's acquisition and served in a number of roles, including as Chief Compliance Officer. Earlier in his career, Mr. Wilson held a role in the Licensing group at Schering-Plough. Mr. Wilson has a B.S. from Saint Joseph's University in Philadelphia, PA and obtained a J.D. from Villanova University Charles Widger School of Law in 2002.

Positions